NNNN

Anbio Biotechnology Class A Ordinary Shares (NNNN)

Name: Anbio Biotechnology Class A Ordinary Shares (NNNN)
Brand: Anbio Biotechnology Class A Ordinary Shares
SKU: NNNN
Price: 28.9 USD
Availability: InStock
Rating: 3 (10 reviews)

Anbio Biotechnology Class A Ordinary Shares (NNNN) 3-star rating from Upturn Advisory

$28.9

Last Close (24-hour delay)

Profit since last BUY-21.89%

WEAK BUY

BUY since 6 days

BUY Advisory
SELL Advisory (Profit)
SELL Advisory (Loss)

Profit
Loss
Pass (Skip investing)

Upturn Stock price based on last close icon

Time period over

Upturn Advisory Summary

12/12/2025: NNNN (3-star) is a REGULAR-BUY. BUY since 6 days. Simulated Profits (-21.89%). Updated daily EoD!

Upturn Star Rating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock

Historic Profit 291.37%

Avg. Invested days 46

Today’s Advisory WEAK BUY

Upturn Star Rating

Upturn Advisory Performance

3.0

Stock Returns Performance

5.0

Profits based on simulation

Last Close 12/12/2025

Key Highlights

Company Size ETF	Market Capitalization 0 USD	Price to earnings Ratio -	1Y Target Price -
Price to earnings Ratio -	1Y Target Price -
Volume (30-day avg) -	Beta -	52 Weeks Range 5.18 - 37.08	Updated Date 05/15/2025
52 Weeks Range 5.18 - 37.08	Updated Date 05/15/2025
Dividends yield (FY) -	Basic EPS (TTM) -

Earnings Date

Report Date -

When -

Estimate -

Actual -

Profitability

Profit Margin -

Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -

Return on Equity (TTM) -

Valuation

Trailing PE -	Forward PE -	Enterprise Value -	Price to Sales(TTM) -
Enterprise Value -	Price to Sales(TTM) -
Enterprise Value to Revenue -	Enterprise Value to EBITDA -	Shares Outstanding -	Shares Floating -
Shares Outstanding -	Shares Floating -
Percent Insiders -	Percent Institutions -

About Anbio Biotechnology Class A Ordinary Shares

Exchange NASDAQ	Headquaters -
IPO Launch date 2025-02-19	CEO -
Sector Healthcare	Industry Medical Instruments & Supplies	Full time employees 27	Website https://www.anbio.com
Full time employees 27	Website https://www.anbio.com

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

https://www.upturn.io

Disclosure Privacy Policy Terms of Use Sitemap Contact Us

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.